The study provided evidence reinforcing the theory that α-thalassemia has a significant effect on CBF and, subsequently, stroke; however, it also failed to find any significant differences between the genotypes of the other two polymorphisms, G6PD and Hp, in terms of CBF [29]. The gene discussed is HP; the disease is thalassemia.